Skip to content

Top Cyber Threats for XR Technology in Healthcare

(Toronto, October 18, 2024)" A new study in JMIR XR and Spatial Computing, published by JMIR Publications, identifies potential cybersecurity and privacy risks associated with the use of Extended Reality (XR) in healthcare. The study, titled “Cybersecurity and Privacy Concerns With Extended Reality Applications in Healthcare: A Scoping Review,” examines the identified potential threats posed by XR technology and strategies to mitigate these risks. The scoping review found few studies specifically addressing cybersecurity in the context of XR use in healthcare. Of the 29 studies examined, only 3 described healthcare applications or services, highlighting a critical research gap. Information disclosure – where personal and health-related data could leak, potentially compromising patient confidentiality – was identified as the greatest potential threat when using XR systems in healthcare. Although various risk mitigation strategies were identified…

more »Top Cyber Threats for XR Technology in Healthcare

Chemical mixture damages nerves

A study by the Helmholtz Centre for Environmental Research (UFZ) provides the first evidence that chemicals in the human body can have neurotoxic effects even when present in amounts below the threshold of effect when considered individually. The scientists strongly advocate for a rethink in risk assessment. Instead of considering individual indicator substances, we must “think in chemical mixtures,” says Prof. Beate […] Chemical mixture damages nerves

Saudi Arabia: Massive investments in environmental technologies

According to Pugnalom, Saudi Arabia is making massive investments in environmental technologies, driving its economic diversification. The desert state is focusing on renewable energy, climate technologies, and innovative environmental solutions. Investments in Climate TechnologiesAccording to a study by venture data company MAGNiTT, Saudi Arabia attracted a total of $68 million in venture capital investments for climate technology startups… Saudi Arabia: Massive investments in environmental technologies

Novartis receives positive CHMP opinion for Kisqali®

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment with Kisqali® (ribociclib) in combination with an aromatase inhibitor. Recommendation is based on the Phase III NATALEE trial, where Kisqali added to endocrine therapy (ET) significantly reduced the risk of recurrence by 25% versus ET alone across a broad population of patients with HR+/HER2- early breast cancer. People with stage II or III HR+/HER2- EBC face significant risk of recurrence – often as incurable metastatic disease – despite adjuvant ET and regardless of nodal involvement. In September, Kisqali was approved by the FDA in this setting5; at ESMO 2024, an updated analysis from NATALEE was presented, showing a deepening invasive disease-free survival benefit. Kisqali® (ribociclib) is a selective cyclin-dependent… 

more »Novartis receives positive CHMP opinion for Kisqali®

Green Biotech: Plant-based collagen market rising to USD 12.3 billion by 2032

Skin is the largest organ (~15% of the total body weight) and represents overall well-being in humans, especially in aging. The global anti-aging market is around USD 64 billion in 2022, and the market size is projected to reach 121.8 billion by 20301. The high-profile products on rejuvenating aged skin are mostly associated with collagen-derived […] Plant-based collagen market will grow to USD 12.3 billion by 2032

Life in Space: Astrobiology for Nonscientists

Over the last two decades alone, new technology and space missions have profoundly changed our understanding of prospective extraterrestrial life in the universe. The resulting field of astrobiology has become a highly eclectic and interdisciplinary pursuit, encompassing many of the natural sciences and holding ramifications for nearly all other areas of study. Co-written by an astrophysicist and a biologist, this introductory undergraduate textbook presents an overview of astrobiology for students from all backgrounds. Addressed in its chapters are the recent detection of potentially habitable planets and the prospects for detecting biosignatures and life; the celestial and geological factors that enabled the appearance and evolution of life on Earth; and other factors that continue to affect life up to the present, such as climate change. Based on over twenty years of university coursework, and in particular the authors’ own interdisciplinary astrobiology… 

more »Life in Space: Astrobiology for Nonscientists

Elhadj As Sy appointed first Chancellor of the Liverpool School of Tropical Medicine

The new Chancellor of the Liverpool School of Tropical Medicine has been announced – internationally recognized humanitarian leader Elhadj As Sy will be formally installed in his role later this year at a ceremony. As brings extensive experience in global health, development, and humanitarian aid, currently serving as Chair of the Kofi Annan Foundation and formerly as Secretary General of the International Federation of Red Cross and Red Crescent Societies. He has also held leadership positions at UNICEF, the United Nations, and the Global Fund. On accepting the role, As said: “It is unacceptable that tropical diseases continue to be neglected. LSTM is responding to this call through education and research to save lives and alleviate suffering for the most vulnerable and hardest-to-reach populations, and I am honored and highly motivated to be its first Chancellor.” The role of Chancellor…

more »Elhadj As Sy appointed first Chancellor of the Liverpool School of Tropical Medicine

Bremen Senate promotes doctor shortage

The doctor shortage in Bremerhaven is intensifying, causing growing tensions between local politics and the Bremen Senate. The situation has continuously worsened in recent years, with a particular shortage of pediatricians becoming apparent[1]. This also has implications for the treatment of diseases resulting from climate change. At the turn of the year 2023/2024, in […] Bremen Senate promotes doctor shortage

TBE: Ticks in Germany now active year-round

The effects of climate change on the spread of tick-borne diseases such as TBE (Tick-Borne Encephalitis) and Lyme disease in Germany are becoming increasingly apparent. Current data show that average temperatures in Germany continue to rise. For example, the annual average temperature in 2024 was 10.5°C according to the German Weather Service, which is 2.3°C above the reference value for the years 1961-1990[1]. This trend continues in 2025, with mild winters and longer periods of warm weather. The rising temperatures have direct impacts on the activity and distribution of ticks, particularly the species Ixodes ricinus, the main vector for TBE and Lyme disease. Experts observe that ticks are now active year-round and no longer take a winter break[2]. This leads to an extended transmission season for tick-borne diseases. The spread of TBE risk areas to the north is particularly concerning. While TBE used to occur mainly in southern Germany, more and more cases are now being registered in the northern federal states. For example, in 2024, the city district of Frankfurt…

more »TBE: Ticks in Germany now active year-round

Sanofi expands into radiopharmaceuticals

  • News

The French pharmaceutical group will invest 300 million euros in a new company that will develop lead isotope-based therapies against cancer. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alpha therapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand drugs. Building on Orano Med's expertise and radioligand pipeline, Sanofi and Orano will invest in a new company that will operate under the Orano Med brand and focus on the discovery, design, and clinical development of next-generation radioligand therapies (RLTs) based on lead-212 (212Pb) alpha-emitting isotopes. This agreement follows Sanofi's announcement of an exclusive license agreement with Orano Med and RadioMedix to advance RLTs in rare cancers with a… 

more »Sanofi expands into radiopharmaceuticals